ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services

Diamond Pharma Services provides regulatory affairs, pharmacovigilance, and compliance & quality services to support pharmaceutical and biotechnology companies in obtaining and maintaining medicinal product licenses throughout all stages of a product’s life cycle.

“We are excited to welcome Diamond Pharma Services into the ProPharma Group family,” says Dawn Sherman, ProPharma Group’s CEO. “This acquisition further solidifies ProPharma Group’s position as the leading global provider of regulatory, compliance, pharmacovigilance, and medical information services. With our mission and higher purpose of improving the health and safety of patients, we are focused on delivering the highest quality of services throughout the full product lifecycle.”

Read more

Source: Private Equity Wire